CATALOG

ITALIAN WEBSITES

Domain and Website Information:

biopredictive.it

Italiano




About site:


Domain name - biopredictive.it


Site title - BioPredictive · Non-invasive diagnostic tests for the liver


Go to website - BioPredictive · Non-invasive diagnostic tests for the liver



Words count at biopredictive.it:

fibrotest - 17
our - 12
tests - 11
and - 10
liver - 10
the - 9
new - 8
test - 8
biopredictive - 6
diagnostic - 6

See complete list



Site GEO location


Location Country - France



Provider - GANDI SAS



biopredictive.it GEO Location on Map



Site Logo



There is no Open Graph data at biopredictive.it


Information for domain biopredictive.it


IP address:

217.70.184.38


Domain name servers:


a.dns.gandi.net b.dns.gandi.net c.dns.gandi.net


All records:


☆ biopredictive.it. 10796 IN A 217.70.184.38
☆ biopredictive.it. 10796 IN NS c.dns.gandi.net.
☆ biopredictive.it. 10796 IN NS b.dns.gandi.net.
☆ biopredictive.it. 10796 IN NS a.dns.gandi.net.
☆ biopredictive.it. 10796 IN SOA a.dns.gandi.net. hostmaster.gandi.net. 1484668036 10800 3600 604800 10800
☆ biopredictive.it. 10796 IN MX 10 spool.mail.gandi.net.
☆ biopredictive.it. 10796 IN MX 50 fb.mail.gandi.net.
☆ biopredictive.it. 10796 IN TXT "v=spf1 include:_mailcust.gandi.net ?all"



Whois server information for biopredictive.it



Brief facts about biopredictive:

FibroTest, known as FibroSure in the US, is a biomarker test that uses the results of six blood serum tests to generate a score that is correlated with the degree of liver damage in people with a variety of liver diseases. FibroTest has the same prognostic value as a liver biopsy. FibroSure uses quantitative results of five serum biochemical markers, α2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, gamma glutamyl transpeptidase, with a patient's age and gender to generate a measure of fibrosis and necroinflammatory activity in the liver. FibroTest has been evaluated in relation to liver biopsy in people with hepatitis C, hepatitis B, alcoholic liver disease, and non-alcoholic fatty liver disease. They are most useful for cirrhosis and less useful for other stages of liver disease. By 2008 it had been used in over 350,000 patients.

Blood tests

Hepatology

 

© DMS 2011-